参考文献/References:
[1] Taneera J, Jin Z, Jin Y,et al. γ-Aminobutyric acid(GABA)signalling in human pancreatic islets is altered in type 2 diabetes[J].Diabetologia,2012,55(7):1985-1994. DOI: 10.1007/s00125-012-2548-7.
[2] Pizarro-Delgado J, Braun M, Hernández-Fisac I,et al. Glucose promotion of GABA metabolism contributes to the stimulation of insulin secretion in β-cells[J].Biochem J,2010,431(3):381-389. DOI: 10.1042/BJ20100714.
[3] Braun M, Ramracheya R, Bengtsson M,et al. Gamma-aminobutyric acid(GABA)is an autocrine excitatory transmitter in human pancreatic beta-cells[J].Diabetes,2010,59(7):1694-1701. DOI: 10.2337/db09-0797.
[4] Bonaventura MM, Crivello M, Ferreira ML,et al. Effects of GABAB receptor agonists and antagonists on glycemia regulation in mice[J].Eur J Pharmacol,2012,677(1-3):188-196. DOI: 10.1016/j.ejphar.2011.12.013.
[5] Rudolph U, Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes[J].Nat Rev Drug Discov,2011,10(9):685-697. DOI: 10.1038/nrd3502.
[6] Rondard P, Goudet C, Kniazeff J,et al. The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors[J].Neuropharmacology,2011,60(1):82-92. DOI: 10.1016/j.neuropharm.2010.08.009.
[7] Dinarello CA. Blocking interleukin-1β in acute and chronic autoinflammatory diseases[J].J Intern Med,2011,269(1):16-28. DOI: 10.1111/j.1365-2796.2010.02313.x.
[8] Mendu SK, Bhandage A, Jin Z,et al. Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes[J].PLoS One,2012,7(8):e42959. DOI: 10.1371/journal.pone.0042959.
[9] Tian J, Dang HN, Yong J,et al. Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice[J].PLoS One,2011,6(9):e25338. DOI: 10.1371/journal.pone.0025338.
[10] Soltani N, Qiu H, Aleksic M,et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes[J].Proc Natl Acad Sci U S A,2011,108(28):11692-11697. DOI: 10.1073/pnas.1102715108.
[11] Tian J, Yong J, Dang H,et al. Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis[J].Autoimmunity,2011,44(6):465-470. DOI: 10.3109/08916934.2011.571223.
[12] Feuerer M, Herrero L, Cipolletta D,et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters[J].Nat Med,2009,15(8):930-939. DOI: 10.1038/nm.2002.
[13] Li C, Liu C, Nissim I,et al. Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine[J].J Biol Chem,2013,288(6):3938-3951. DOI: 10.1074/jbc.M112.385682.
[14] Prud'homme GJ, Glinka Y, Hasilo C,et al. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone[J].Transplantation,2013,96(7):616-623. DOI: 10.1097/TP.0b013e31829c24be.
[15] Tian J, Dang H, Chen Z,et al. γ-Aminobutyric acid regulates both the survival and replication of human β-cells[J].Diabetes,2013,62(11):3760-3765. DOI: 10.2337/db13-0931.
[16] Prud'homme GJ, Glinka Y, Udovyk O,et al. GABA protects pancreatic beta cells against apoptosis by increasing SIRT1 expression and activity[J].Biochem Biophys Res Commun,2014,452(3):649-654. DOI: 10.1016/j.bbrc.2014.08.135.
[17] Purwana I, Zheng J, Li X,et al. GABA promotes human β-cell proliferation and modulates glucose homeostasis[J].Diabetes,2014,63(12):4197-4205. DOI: 10.2337/db14-0153.
[18] Wan Y, Wang Q, Prud'homme GJ. GABAergic system in the endocrine pancreas: a new target for diabetes treatment[J].Diabetes Metab Syndr Obes,2015,8:79-87. DOI: 10.2147/DMSO.S50642.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(01):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(01):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(01):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(01):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(01):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(01):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(01):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(01):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
[11]陈琦 袁莉.γ-氨基丁酸能信号系统与胰岛素抵抗[J].国际内分泌代谢杂志,2020,40(02):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]
Chen Qi,Yuan Li.Relationship between γ-aminobutyric acid signaling system and insulin resistance[J].International Journal of Endocrinology and Metabolism,2020,40(01):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]